212 related articles for article (PubMed ID: 12048197)
21. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
[TBL] [Abstract][Full Text] [Related]
22. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
Takagi Y; Pause A; Conaway RC; Conaway JW
J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.
Skowyra D; Koepp DM; Kamura T; Conrad MN; Conaway RC; Conaway JW; Elledge SJ; Harper JW
Science; 1999 Apr; 284(5414):662-5. PubMed ID: 10213692
[TBL] [Abstract][Full Text] [Related]
24. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH
J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.
Ohta T; Xiong Y
Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432
[TBL] [Abstract][Full Text] [Related]
26. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890
[TBL] [Abstract][Full Text] [Related]
27. The von Hippel-Lindau tumour suppressor protein: new perspectives.
Ohh M; Kaelin WG
Mol Med Today; 1999 Jun; 5(6):257-63. PubMed ID: 10366821
[TBL] [Abstract][Full Text] [Related]
28. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.
Okuda H; Saitoh K; Hirai S; Iwai K; Takaki Y; Baba M; Minato N; Ohno S; Shuin T
J Biol Chem; 2001 Nov; 276(47):43611-7. PubMed ID: 11574546
[TBL] [Abstract][Full Text] [Related]
29. Roles of SCF and VHL ubiquitin ligases in regulation of cell growth.
Kamura T; Conaway JW; Conaway RC
Prog Mol Subcell Biol; 2002; 29():1-15. PubMed ID: 11908068
[No Abstract] [Full Text] [Related]
30. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.
Zheng N; Schulman BA; Song L; Miller JJ; Jeffrey PD; Wang P; Chu C; Koepp DM; Elledge SJ; Pagano M; Conaway RC; Conaway JW; Harper JW; Pavletich NP
Nature; 2002 Apr; 416(6882):703-9. PubMed ID: 11961546
[TBL] [Abstract][Full Text] [Related]
31. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
32. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
34. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.
Querido E; Blanchette P; Yan Q; Kamura T; Morrison M; Boivin D; Kaelin WG; Conaway RC; Conaway JW; Branton PE
Genes Dev; 2001 Dec; 15(23):3104-17. PubMed ID: 11731475
[TBL] [Abstract][Full Text] [Related]
35. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.
Lonergan KM; Iliopoulos O; Ohh M; Kamura T; Conaway RC; Conaway JW; Kaelin WG
Mol Cell Biol; 1998 Feb; 18(2):732-41. PubMed ID: 9447969
[TBL] [Abstract][Full Text] [Related]
36. One ring to rule a superfamily of E3 ubiquitin ligases.
Tyers M; Willems AR
Science; 1999 Apr; 284(5414):601, 603-4. PubMed ID: 10328744
[No Abstract] [Full Text] [Related]
37. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.
Stebbins CE; Kaelin WG; Pavletich NP
Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047
[TBL] [Abstract][Full Text] [Related]
38. Interaction between Mnk2 and CBC(VHL) ubiquitin ligase E3 complex.
Wang P; Wang X; Wang F; Cai T; Luo Y
Sci China C Life Sci; 2006 Jun; 49(3):265-73. PubMed ID: 16856496
[TBL] [Abstract][Full Text] [Related]
39. SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.
Willems AR; Goh T; Taylor L; Chernushevich I; Shevchenko A; Tyers M
Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1533-50. PubMed ID: 10582239
[TBL] [Abstract][Full Text] [Related]
40. Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins.
Furukawa M; Ohta T; Xiong Y
J Biol Chem; 2002 May; 277(18):15758-65. PubMed ID: 11861641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
